Sarah Stone is a Wenatchee, Washington based neurologist with 11 years of experience in Neuromuscular Medicine. She completed her graduation from Wake Forest University School Of Medicine in 2014. She is also affiliated with hospitals like and . She accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Sarah Stone is MD61100339 for Neurology in Washington. Her current practice location is 1201 S Miller St, Wenatchee. Patients can reach her at 509-663-8711. Sarah Stone NPI number (Unique professional ID assigned by NPPES) is 1972921682.
Sarah Stone is a neurologist or child neurologist who specializes in the diagnosis and management of disorders of nerve, muscle or neuromuscular junction, including amyotrophic lateral sclerosis, peripheral neuropathies (e.g., diabetic and immune mediated neuropathies), various muscular dystrophies, congenital and acquired myopathies, inflammatory myopathies (e.g., polymyositis, inclusion body myositis) and neuromuscular transmission disorders (e.g., myasthenia gravis, Lambert-Eaton myasthenic syndrome).
Complete Profile:
Sarah Stone speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
| Name: | Sarah Stone |
| Specialization: | Neuromuscular Medicine |
| Gender: | Female |
| Experience: | 11+ years |
| Medical School Attended: | Wake Forest University School Of Medicine |
| Graduation Year: | 2014 |
| Accepts Medicare Assignment: | Yes |
| Practice Address: | 1201 S Miller St, Wenatchee,
Washington, 98801-3201 |
| Phone: | 509-663-8711 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| PAC ID: | 7315241882 |
| Enrollment ID: | I20201110003399 |
| NPI Number: | 1972921682 |
| NPI Enumeration Date: | 31 Mar, 2014 |
| NPI Last Update On: | 10 Nov, 2022 |
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Sarah Stone are as mentioned below.
| License Number | Specialization | State | Status | |
| MD61100339 | Neurology | Washington | Primary | |
| 23027 | Neuromuscular Medicine | Maine | Secondary | |
| MD61100339 | Neuromuscular Medicine | Washington | Secondary | |
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
| Hospital Name (CCN) | State | Hospital Type |
| (500016) | Wenatchee, WA | Acute Care Hospital |
| (500148) | Wenatchee, WA | Acute Care Hospital |
| (501328) | Omak, WA | Critical Access Hospital |
| (501317) | Ephrata, WA | Critical Access Hospital |
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Sarah Stone is associated with along with the number of members in that group.
| Organization Name (Group PAC ID) | Members |
| Central Washington Health Services Association (4880504596) | 192 |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Sarah Stone
820 N Chelan Ave,
Wenatchee, Washington |
| Zip: | 98801-2028 |
| Phone Number: | 509-663-8711 |
Patients can reach Sarah Stone at
1201 S Miller St, Wenatchee, Washington or can
call to book an appointment on 509-663-8711.
Comments/ Reviews:
Read all the reviews posted for Sarah Stone below. You may also share your own experience with Sarah Stone. Your feedback can help others make better decisions.
**
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.